SREBP1 is a central regulator, but other factors and feedback loops (such as HBXIP and glutamine synthetase) can compensate if SREBP1 is inhibited, allowing cancer cells to maintain lipid synthesis and survival [37,40,91,92,134]. The gene discussed is GLUL; the disease is cancer.